It has long been known that the intraperitoneal administration of zymosan, a particulate compound extracted from the yeast cell wall and containing β-1,3/1,6 glucans, induces peritonitis and, consequently, the release of inflammatory cytokines, including IL-1β (45). This evidence concerns the gene IL1B and peritonitis.